About Regulator of G-protein signaling 11
Regulator of G-protein signaling 11 (RGS11) is a protein
from Homo sapiens identified by UniProt accession
O94810, 467 residues long.
MolForge cross-references it against 0 known binders and
59 disease associations.
Target properties
| Protein name | Regulator of G-protein signaling 11 |
| UniProt accession | O94810 |
| Gene | RGS11 |
| Organism | Homo sapiens |
| Length | 467 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (59)
Diseases linked to this target (Open Targets).
- mean corpuscular hemoglobin · score 0.53
- mean corpuscular volume · score 0.36
- mean corpuscular hemoglobin concentration · score 0.26
- lung adenocarcinoma · score 0.23
- head and neck squamous cell carcinoma · score 0.23
- esophageal cancer · score 0.23
- gastric adenocarcinoma · score 0.23
- neurodegenerative disease · score 0.21
- HbA1c measurement · score 0.21
- erythrocyte count · score 0.18
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-O94810-F1 | alphafold | PREDICTED | 86.11 | — |
Amino-acid sequence (467 residues)
MAAGPAPPPG RPRAQMPHLR KMERVVVSMQ DPDQGVKMRS QRLLVTVIPH AVTGSDVVQW LAQKFCVSEE EALHLGAVLV QHGYIYPLRD PRSLMLRPDE TPYRFQTPYF WTSTLRPAAE LDYAIYLAKK NIRKRGTLVD YEKDCYDRLH KKINHAWDLV LMQAREQLRA AKQRSKGDRL VIACQEQTYW LVNRPPPGAP DVLEQGPGRG SCAASRVLMT KSADFHKREI EYFRKALGRT RVKSSVCLEA YLSFCGQRGP HDPLVSGCLP SNPWISDNDA YWVMNAPTVA APTKLRVERW GFSFRELLED PVGRAHFMDF LGKEFSGENL SFWEACEELR YGAQAQVPTL VDAVYEQFLA PGAAHWVNID SRTMEQTLEG LRQPHRYVLD DAQLHIYMLM KKDSYPRFLK SDMYKALLAE AGIPLEMKRR VFPFTWRPRH SSPSPALLPT PVEPTAACGP GGGDGVA
Explore Regulator of G-protein signaling 11 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets